In utero ventriculosubgaleal shunt placement in a fetal lamb model: Phase 1 technical insights

Abstract Background Progressive ventriculomegaly and the resulting irreversible brain damage may be mitigated through timely diversion prenatal intervention. While ventriculosubgaleal shunt (VSGS) is commonly performed postnatally in premature infants, in utero placement is unexplored. Objectives We evaluated the feasibility of intrauterine placement of VSGS using a fetal lamb obstructive hydrocephalus model. Study Design Hydrocephalus was induced in 14 fetal lambs by injecting 1–1.5 mL of BioGlueⓇ into the cisterna magna between Days 80 and 90 of gestation. Ten to 16 days later, ultrasound was performed to confirm hydrocephalus. Afterward, VSGS was surgically placed by creating a fetal subgaleal pocket, inserting a standard ventricular catheter, tunneling under the scalp, and securing with a silk suture, with the other end into a lateral ventricle. Near term, the ewes were sacrificed. Hysterotomy was performed to extract the lambs. Lambs were evaluated through gross inspection. Postmortem magnetic resonance imaging and pathology evaluations were performed. To assess the presence of activated microglia and astroglia, selected brain sections were immuno‐stained with ionized calcium‐binding adaptor molecule 1 (Iba1) and glial fibrillary acidic protein (GFAP), respectively. Results Ten ewes with 14 fetuses (four twins) underwent hydrocephalus induction (median 86 days) by maternal laparotomy and either hysterotomy (two out of 14) or transuterine (12 out of 14) methods. Two fetuses were found demised at the time of shunt placement; hydrocephalus was confirmed in 11/12 surviving fetuses (three severe, four moderates, and four mild). A VSGS was successfully placed in all 12 surviving fetuses (median 104 days) employing open uterus fetal surgery. After shunt placement, one case died immediately from severe hydrocephalus, three were aborted, and one intrauterine fetal demise was found during cesarean delivery. Of the remaining seven lambs, seven out of seven VSGS remained under the scalp without catheter migration, and all demonstrated full scalp healing. Pathologic analyses by gross and histological methods confirmed typical hydrocephalic changes, including altered and denuded ependyma. However, more than half of the catheters were macroscopically obstructed with tissue debris and fibrin (four out of seven). Conclusion Prenatal placement of the VSGS was technically successful in all cases, meaning the shunt could be inserted in 100% of fetuses. Survival to cesarean delivery was 58% (seven out of 12). Among survivors, no hardware migration or scalp breakdown occurred. Future studies should further explore the safety of the shunt.

Authors

Institutions

Publication Details

Journal
Pregnancy
Published
2026-05-29
DOI
https://doi.org/10.1002/pmf2.70328
Primary Topic
Fetal and Pediatric Neurological Disorders
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

In utero ventriculosubgaleal shunt placement in a fetal lamb model: Phase 1 technical insights

Soner Duru, Shohra Qaderi, Scott A. Shainker, Eyal Krispin et al.
Pregnancy
Fetal and Pediatric Neurological Disorders
article

In utero ventriculosubgaleal shunt placement in a fetal lamb model: Phase 1 technical insights

Soner Duru, Shohra Qaderi, Scott A. Shainker, Eyal Krispin, José L. Peiró, Ryne A. Didier, Nikan Zargarzadeh, Weston T. Northam, Lana Vasung, Braxton Forde, Lucas Peiro, B. C. Warf, P Ellen Grant, Kjersti Aagaard, A Javinani, Brittany Pattison, Syril James, Hamidreza Forourtan, Arthur Nedder, Yves Ville, Darren B. Orbach, Alireza A. Shamshirsaz, Sebastian Seifert, Ramen H. Chmait, Michaela K. Farber
article en

Abstract

Abstract Background Progressive ventriculomegaly and the resulting irreversible brain damage may be mitigated through timely diversion prenatal intervention. While ventriculosubgaleal shunt (VSGS) is commonly performed postnatally in premature infants, in utero placement is unexplored. Objectives We evaluated the feasibility of intrauterine placement of VSGS using a fetal lamb obstructive hydrocephalus model. Study Design Hydrocephalus was induced in 14 fetal lambs by injecting 1–1.5 mL of BioGlueⓇ into the cisterna magna between Days 80 and 90 of gestation. Ten to 16 days later, ultrasound was performed to confirm hydrocephalus. Afterward, VSGS was surgically placed by creating a fetal subgaleal pocket, inserting a standard ventricular catheter, tunneling under the scalp, and securing with a silk suture, with the other end into a lateral ventricle. Near term, the ewes were sacrificed. Hysterotomy was performed to extract the lambs. Lambs were evaluated through gross inspection. Postmortem magnetic resonance imaging and pathology evaluations were performed. To assess the presence of activated microglia and astroglia, selected brain sections were immuno‐stained with ionized calcium‐binding adaptor molecule 1 (Iba1) and glial fibrillary acidic protein (GFAP), respectively. Results Ten ewes with 14 fetuses (four twins) underwent hydrocephalus induction (median 86 days) by maternal laparotomy and either hysterotomy (two out of 14) or transuterine (12 out of 14) methods. Two fetuses were found demised at the time of shunt placement; hydrocephalus was confirmed in 11/12 surviving fetuses (three severe, four moderates, and four mild). A VSGS was successfully placed in all 12 surviving fetuses (median 104 days) employing open uterus fetal surgery. After shunt placement, one case died immediately from severe hydrocephalus, three were aborted, and one intrauterine fetal demise was found during cesarean delivery. Of the remaining seven lambs, seven out of seven VSGS remained under the scalp without catheter migration, and all demonstrated full scalp healing. Pathologic analyses by gross and histological methods confirmed typical hydrocephalic changes, including altered and denuded ependyma. However, more than half of the catheters were macroscopically obstructed with tissue debris and fibrin (four out of seven). Conclusion Prenatal placement of the VSGS was technically successful in all cases, meaning the shunt could be inserted in 100% of fetuses. Survival to cesarean delivery was 58% (seven out of 12). Among survivors, no hardware migration or scalp breakdown occurred. Future studies should further explore the safety of the shunt.

PregnancyVol. 2(4)
University of Southern California (US), Brigham and Women's Hospital (US), Cincinnati Children's Hospital Medical Center (US), Hôpital Necker-Enfants Malades (FR), Boston Children's Hospital (US), Beth Israel Deaconess Medical Center (US), Harvard University (US), Shiraz University of Medical Sciences (IR), Université Paris Cité (FR), HCA Healthcare (US), Society for Maternal-Fetal Medicine (US), Cincinnati VA Medical Center (US), Boston Children's Museum (US), University of Cincinnati (US)
Boston Children's Hospital
Openalex Percentile: Top 5%
Fetal and Pediatric Neurological Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.